Hyperbaric oxygen therapy and cerebral palsy - Where to now?

Undersea and Hyperbaric Medicine

Volumn 34, Issue 2, 2007, Pages 69-74

  Bennett, M ^a   Newton, H ^b,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBRAL PALSY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EDITORIAL; HUMAN; HYPERBARIC OXYGEN; MOTIVATION; PEER REVIEW; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; STANDARD;

CEREBRAL PALSY; CHILD; HUMANS; HYPERBARIC OXYGENATION; MOTIVATION; PEER REVIEW, RESEARCH; RANDOMIZED CONTROLLED TRIALS;

EID: 34250332976     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (35)

1. Machado JJ. Clinically observed reduction of spacticity in patients with neurological diseases and in children with cerebral palsy from hyperbaric oxygen therapy. http://www.hypertc.com/web%20research/cp%20and%20neuro%20disf.doc 1989.
2. Collet JP, Vanasse M, Marois P, Amar M, Goldberg J, Lambert J et al. Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. HBO-CP Research Group. Lancet 357(9256):582-6, 2001.
3. Montgomery D, Goldberg J, Amar M, Lacroix V, Lecomte J, Lambert J et al. Effects of hyperbaric oxygen therapy on children with spastic diplegic cerebral palsy: a pilot project. Undersea Hyperb Med 26(4):235-42, 1999.
4. Nuthall G, Seear M, Lepawsky M, Wensley D, Skippen P, Hukin J. Hyperbaric oxygen therapy for cerebral palsy: two complications of treatment. Pediatrics 106(6):E80, 2000.
5. Mathai SS, Bansali P, Singh Gill B, Nagpal S, John MJ, Aggarwal H, Bhatt V. Effects of hyperbaric oxygen therapy in children with cerebral palsy. In: Proceedings of the International Conference on Diving and Hyperbaric Medicine, Barcelona 7-10 SeptemberDesola J, editor.Barcelona, Spain: EUBS; 2005.
6. Packard M. The Cornell Study. http://www.netnet/mums/Cornell.htm 2000.
7. Neubauer RA. Hyperbaric oxygenation for cerebral palsy. Lancet 2001; 357(June 23):2052.
8. Chavdarov I. The effects of hyperbaric oxygenation on psycho-motor functions by children with cerebral palsy. In: The Proceedings of the 2nd International Symposium on Hyperbaric Oxygenation for Cerebral Palsy and the Brain-Injured Child, Joiner JT, editor. Flagstaff, Az: Best Publishing; 2002.
9. Muller-Bolla M, Collet JP, Ducruet T, Robinson A. Side effects of hyperbaric oxygen therapy in children with cerebral palsy. Undersea Hyperb Med 33(4):237-44, 2006.
10. Scientific Advisory Committee. Report: Hyperbaric oxygen therapy for children with cerebral palsy: a multicenter randomised clinical trial. Quebec, Canada: Fonds dela recherche en sante du Quebec; 2000.
11. Jan MM. Cerebral palsy: Comprehensive review and update. Ann Saudi Med 2006; 26(2): 123-132.
12. Paneth N, Hong T, Korzeniewski S. The descriptive epidemiology of cerebral palsy. Clinical Perinatology 2006; 33:251-267.
13. Amato M, Donati F. Update on perinatal hypoxic insult: mechanism, diagnosis and interventions. European Journal of Paediatric Neurology 2000; 4:203-209.
14. Hack M, Freidman H, Fanaroff A. Outcomes of extremely low birth weight infants. Pediatrics 1996; 98:913-937.
15. Koman LA, Smith BP, Shilt JS. Cerebral palsy. The Lancet 2004; 363(May 15): 1619-1631.
16. Zafeiriou DI, Kontopoulos EE, Tsikoulas I. Characteristics and prognosis of epilepsy in children with cerebral palsy. Journal of Child Neurology 1999; 14(5):289-294.
17. Kirton A, deVeber G. Cerebral palsy secondary to perinatal ischemic stroke. Clinical Perinatology 2006; 33:367-386.
18. Noetzel MJ. Perinatal trauma and cerebral palsy. Clinical Perinatology 2006; 33:355-366.
19. Hermansen MC, Hermansen MG. Perinatal infections and cerebral palsy. Clinical Perinatology 2006; 33:315-333.
20. Menkes JH, Flores-Sarnat L. Cerebral palsy due to chromosomal anomalies and continuous gene syndromes. Clinical Perinatology 2006; 33:481-501.
21. Folkerth RD. Neuropathologic substrate of cerebral palsy. Journal of Child Neurology 2005; 20:940-949.
22. Baud O, Haynes RF, Wang H. Developmental up-regulation of MnSOD in rat oligodendrocytes confers protection against oxidative injury. European Journal of Neuroscience 2004; 20:29-40.
23. Deng W, Rosenberg PA, Volpe JJ, Jensen FE. Calcium-permeable AMPA/kainite receptors mediate toxicity and preconditioning by oxygen- glucose deprivation in oligodendrocyte precursors. Proceedings of the National Academy of Science USA 2003; 100:6801-6806.
24. Liu HN, Giasson BI, Mushynski WE, lmazan G. AMPA receptor-mediated toxicity in oligodendrocyte progenitors involves free radical generation and activation of JNK, calpain, and caspase 3. Journal of Neurochemistry 2002; 82:398-409.
25. Agresti C, Bernardo A, Del Russo N. Synergistic stimulation of MHC class I and IRF-1 gene expression by IFN-gamma and TNF-alpha in oligodendrocytes. European Journal of Neuroscience 1998; 10:2975-2983.
26. Perlman JM. Intervention strategies for neonatal hypoxic-ischaemic cerebral injury. Clinical Therapeutics 2006; 28(9):1353-1365.
27. Patel DR. Therapeutic interventions in cerebral palsy. Indian Journal of Paediatrics 2005; 72:979-983.
28. Steinbok P. Selection of treatment modalities in children with spastic cerebral palsy. Neurosurgical Focus 2006; 21(2):l-8.
29. Nordmark E, Jarnlo GB, Hagglund G. Comparison of the Gross Motor Function Measure and Paediatric Evaluation of Disability Inventory in assessing motor function in children undergoing selective dorsal rhizotomy. Developmental Medicine & Child Neurology 2000; 42(4):245-252.
30. Mclaughlin J, Bjornson K, Temkin L. Selective dorsal rhizotomy: meta-analysis of three randomised controlled trials. Developmental Medicine & Child Neurology 2002; 44(1): 17-25.
31. Marois P, Vanasse M. Hyperbaric oxygen therapy and cerebral palsy [comment]. Developmental Medicine & Child Neurology 45(9):646-7; author reply 647-8, 2003.
32. Heuser,G., Heuser SA, Rodelander D, Aguilera O, Uszler M. Treatment of neurologically impaired adults and children with 'mild' hyperbaric oxygenation (1.3 ATA and 24% oxygen). In: The Proceedings of the 2nd International Symposium on Hyperbaric Oxygenation for Cerebral Palsy and the Brain-Injured Child, Joiner JT, editor. Flagstaff Az: Best Publishing; 2002.
33. Essex C. Hyperbaric oxygen and cerebral palsy: no proven benefit and potentially harmful. Developmental Medicine & Child Neurology 2003; 45(3):213-5.
34. Edwards SJ, Lilford RJ, Braunholtz DA, Jackson JC, Hewison J, Thornton J. Ethical issues in the design and conduct of randomised controlled trials: a review. Health Technology Assessment 1998; 2(15):1-132.
35. Lantos JD. The "inclusion benefit" in clinical trials. Journal of Pediatrics 1999; 134:130-131.